Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

被引：0
|
作者：
Rima Patel
Zhiqiang Li
Brittney S. Zimmerman
Marc Y. Fink
Jason D. Wells
Xiang Zhou
Kristin Ayers
Arielle Redfern
Scott Newman
Eric Schadt
William K. Oh
Rong Chen
Amy Tiersten
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology
[2] Sema4,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Metastatic breast cancer; Obesity; Aromatase inhibitors; Hormone positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 319
页数：6
相关论文
共 50 条
  • [21] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
    M A N Sendur
    S Aksoy
    N Zengin
    K Altundag
    British Journal of Cancer, 2012, 107 : 1815 - 1819
  • [22] Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer
    Elliott, K. M.
    Dent, J.
    Stanczyk, F. Z.
    Woodley, L.
    Coombes, R. C.
    Purohit, A.
    Palmieri, C.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (08) : 939 - 948
  • [23] Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer
    Martel, Samuel
    Poletto, Elena
    Ferreira, Arlindo R.
    Lambertini, Matteo
    Sottotetti, Federico
    Bertolini, Ilaria
    Montemurro, Filippo
    Bernardo, Antonio
    Risi, Emanuela
    Zanardi, Elisa
    Ziliani, Serena
    Mura, Silvia
    Dellepiane, Chiara
    Del Mastro, Lucia
    Minisini, Alessandro Marco
    Puglisi, Fabio
    BREAST, 2018, 37 : 142 - 147
  • [24] Impact of aromatase inhibitors on bone health in breast cancer patients
    Geisler, Jurgen
    Lonning, Per E.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 118 (4-5): : 294 - 299
  • [25] BODY MASS INDEX AND PROGNOSIS OF WOMEN WITH METASTATIC BREAST CANCER
    Gennari, A.
    Amadori, D.
    Nanni, O.
    Decensi, A.
    Conte, P. F.
    Puntoni, M.
    Bruzzi, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 119
  • [26] Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor
    Ohara, Masahiro
    Akimoto, Etsushi
    Noma, Midori
    Matsuura, Kazuo
    Doi, Mihoko
    Kagawa, Naoki
    Itamoto, Toshiyuki
    ONCOLOGY LETTERS, 2015, 10 (05) : 3286 - 3292
  • [27] Effect of body mass index on metastatic pattern in early breast cancer patients.
    Yazici, Ozan
    Aksoy, Sercan
    Sendur, Mehmet Ali Nahit
    Ozdemir, Nuriye
    Zengin, Nurullah
    Altundag, Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin
    Barba, Maddalena
    Pizzuti, Laura
    Sperduti, Isabella
    Natoli, Clara
    Gamucci, Teresa
    Sergi, Domenico
    Di Lauro, Luigi
    Moscetti, Luca
    Izzo, Fiorentino
    Rinaldi, Massimo
    Mentuccia, Lucia
    Vaccaro, Angela
    Iezzi, Laura
    Grassadonia, Antonino
    Michelotti, Andrea
    Landucci, Elisabetta
    Perracchio, Letizia
    Pescarmona, Edoardo
    Di Filippo, Franco
    Giordano, Antonio
    Maugeri-Sacca, Marcello
    Vici, Patrizia
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (05) : 986 - 991
  • [29] A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer
    Rose, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S9 - S16
  • [30] Aromatase inhibitors and metastatic breast cancer survival.
    Abrial, C
    Leheurteur, M
    Cabrespine, A
    Mouret-Reynier, MA
    Durando, X
    Ferrière, JP
    Kwiatkowski, F
    Penault-Llorca, F
    Curé, H
    Chollet, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 69S - 69S
12345